Patent No.: US 8952006 B2
USOO8952006B2 (12) United States Patent (10) Patent No.: US 8,952,006 B2 Cundy et al. (45) Date of Patent: *Feb. 10, 2015 (54) MORPHOLINOALKYL FUMARATE FOREIGN PATENT DOCUMENTS COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE W. wo.5: 886 WO WO O2/O55063 T 2002 (71) Applicant: XenoPort, Inc., Santa Clara, CA (US) WO WO O2/O55066 T 2002 WO WOO3,087.174 10, 2003 (72) Inventors: Kenneth C. Cundy, Redwood City, CA WO WO 2005/023241 3, 2005 WO WO 2005/027899 3, 2005 (US); Suresh K. Manthati, Sunnyvale, WO WO 2006/037342 4/2006 CA (US); David J. Wustrow, Los Gatos, WO WO 2006/122652 11, 2006 CA (US) WO WO 2007/042034 4/2007 WO 2010/022177 A2 2, 2010 (73) Assignee: XenoPort, Inc., Santa Clara, CA (US) WO 2014/0964.25 A2 6, 2014 (*) Notice: Subject to any disclaimer, the term of this OTHER PUBLICATIONS patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050 2057.* spent is Subject to a terminal dis- Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992 1996.* (21) Appl. No.: 13/761,864 Ey's statisfy it to (22) Filed: Feb. 7, 2013 com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/index. e f 9 html>. (65) Prior Publication Data Atreya et al., NF-kB in inflammatory bowel disease, J Intern Med (2008), 263(6): 591-6. US 2013/02O3753 A1 Aug. 8, 2013 Bardgett et al., NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57B1/6 mice, Brain Res Bull (2003), 60: 131-142.
[Show full text]